论文信息 - SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021 - 字舞流文

SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021

Sarika | Divya Tej Sowpati | J. Babu | A. Laxmaiah | N. Arlappa | I. Meshram | D. T. Sowpati | Surabhi Srivastava | T. S. Santhosh Kumar | Paras Sharma | R. Hemalatha | M. Surekha | P. Blessy | R. Ananthan | R. Sabarinathan | S. Devendra | Priya Singh | M. M. Mahesh Kumar | B. Naveen Kumar | P. Raghu | J. Srinivasa Rao | K. Tallapaka | R. Mishra | Deepak Sharma | Deepak Kumar | B. Santosh Kumar | K. Rajender Rao | G. Subba Rao | M. Murekhar | D. Kumar | N. Rao | P. Devaraj | F. Sylvia | P. Ravindranadh | P. Raghavendra | P. U. Kumar | V. Mahesh Anumalla | M. Santhos Kumar

[1] N. Sharma,et al. The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study. , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2] P. Vallois,et al. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France , 2021, Viruses.

[3] F. Napolitano,et al. Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy , 2021, International journal of environmental research and public health.

[4] Sarang V Dhatrak,et al. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 , 2021, International Journal of Infectious Diseases.

[5] H. Clapham,et al. COVID-19 serosurveys for public health decision making , 2021, The Lancet Global Health.

[6] C. Viboud,et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis , 2021, The Lancet Global Health.

[7] Ashish,et al. Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations , 2021, medRxiv.

[8] A. Malani,et al. SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020 , 2021, medRxiv.

[9] M. Mohanan,et al. Prevalence of SARS-CoV-2 in Karnataka, India. , 2021, JAMA.

[10] T. Bhatnagar,et al. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India , 2021, Emerging infectious diseases.

[11] Bhavin Solanki,et al. Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study , 2021, BMJ Open.

[12] G. Kang,et al. Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India , 2020, The Lancet Global Health.

[13] S. Iyer,et al. COVID-19 seroprevalence study of an Indian Diagnostic Laboratory - Report on gender and age analysis , 2020, Asian Journal of Health Sciences.

[14] S. Zhikrivetskaya,et al. Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study , 2020, Scientific Reports.

[15] P. Hsueh,et al. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review , 2020, International Journal of Infectious Diseases.

[16] C. Viboud,et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis , 2020, The Lancet Global Health.

[17] S. Majid,et al. Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India – A cross-sectional study , 2020, bioRxiv.

[18] G. Kang,et al. Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020 , 2020, medRxiv.

[19] D. Sin,et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 , 2020, European Respiratory Journal.

[20] P. K. Anand,et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 , 2020, The Indian journal of medical research.